Developer docs
API playgroundTry for free, no card

Search company profiles

Cambridge University Hospitals NHS Foundation Trust

Full company profile

uuid00053io

Namestring
Cambridge University Hospitals NHS Foundation Trust
Legal namestring
Cambridge University Hospitals NHS Foundation Trust
Websiteurl
cuh.nhs.uk
Company typeenum
Private
Founded yearint
1992
Descriptiontext

Cambridge University Hospitals NHS Foundation Trust (CUH) is a UK NHS Foundation Trust — a public benefit corporation — that operates Addenbrooke's Hospital and The Rosie Hospital from a single site on Hills Road, Cambridge, as the regional specialist centre for the East of England. It delivers acute, specialist and tertiary services — emergency care, cancer, cardiology, children's services, maternity, robotic surgery and clinical research — to a population of approximately 5 million, with around 1 million patient contacts per year and 10,000+ employees.

Its technology stack is anchored by an Epic electronic health record that powers the MyChart patient portal and underpins an Epic-based Digital Research Environment used for AI/ML research on de-identified data. The Trust additionally hosts the East of England Secure Data Environment (EoE SDE), runs the OPTICA patient-flow application on the NHS Federated Data Platform, operates a CAR-T cell manufacturing laboratory built with the University of Cambridge, and runs the Cambridge Digital Health and Surgical Training Centre with hands-on training on da Vinci, Versius and Hugo RAS robotic surgery systems plus extended reality and AI-based immersive training.

CUH's revenue model is dominated by statutory NHS funding for public healthcare delivery, supplemented by competitive research grants (e.g., a £1.4m NIHR grant for the CAR-T lab), a five-year Strategic Research Agreement with Arcturis (formerly Sensyne Health) licensing access to 3 million de-identified patient records in exchange for a 2.6% equity stake, up to £350,000/year IT investment and royalties, philanthropic donations via Addenbrooke's Charitable Trust (including a £10m gift), and income from private and overseas patients through the Paying Patients Office. Services are free at the point of use for NHS patients; pricing for non-NHS patients is not publicly listed.

Short descriptiontext

Cambridge University Hospitals NHS Foundation Trust operates Addenbrooke's Hospital and The Rosie Hospital in Cambridge, delivering acute, specialist, maternity and tertiary NHS services to approximately 5 million people across the East of England while serving as a major translational clinical research and AI-data hub.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersCambridge, United Kingdom
HQ citystring
Cambridge
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
acute hospital services, tertiary healthcare services, clinical research trials, maternity hospital care, emergency medical services
Product category
Acute Hospital Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Statutory NHS funding
TypeManaged Services
Description

Primary funding as an NHS Foundation Trust delivering public healthcare services free at the point of use across Cambridgeshire, Peterborough, and the East of England region.

cuh.nhs.uk
2Strategic Research Agreement with Arcturis (formerly Sensyne Health)
TypeLicensing Royalties
Description

Five-year SRA signed December 2021 providing non-exclusive access to three million longitudinal de-identified patient records. CUH received 4,285,714 ordinary shares (2.6% of Sensyne) and an investment of up to £350,000 per year, plus royalties on revenues generated by Sensyne from research under the SRA.

cuh.nhs.uk
3Charitable donations via Addenbrooke's Charitable Trust (ACT)
TypeTransaction Fee
Description

Donations and philanthropy supporting the Trust's work, including a £10m donation from a New Zealand businessman to establish the Charlotte Lockhart Precision Breast Cancer Institute.

cuh.nhs.uk
4Research grants (NIHR)
TypeSubscription Recurring
Description

Competitive grant funding such as the £1.4 million grant from the NIHR supporting the new CAR-T cell manufacturing laboratory at Addenbrooke's Hospital.

businessweekly.co.uk
5Paying Patients Office (private/overseas patient income)
TypeManaged Services
Description

Income from overseas patients and private/overseas patient services managed through the Paying Patients Office.

cuh.nhs.uk
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Others
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 5 records shown
1MyChart
Description

Patient portal app launched by CUH providing secure online access to health records, appointments, medication, messages and test results.

cuh.nhs.uk
+4 more records
Core offering1 text field

Cambridge University Hospitals NHS Foundation Trust operates Addenbrooke's Hospital and The Rosie Hospital in Cambridge, delivering acute, specialist, and tertiary healthcare services to a population of approximately five million across the East of England. The Trust provides a full clinical service portfolio including emergency, cancer, cardiology, children's, maternity, imaging, and outpatient services, supported by digital tools (MyChart, CUH Directions), research platforms (East of England Secure Data Environment), a CAR-T cell manufacturing laboratory, and the Cambridge Digital Health and Surgical Training Centre.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Robot-assisted Whipple's procedures (East of England first) - patients reported minimal pain and speedy recovery compared to traditional surgery which typically requires several months of recovery
+3 more records
Product overview1 text field

Cambridge University Hospitals NHS Foundation Trust (CUH) is a UK NHS acute hospital trust operating two core hospital sites — Addenbrooke's Hospital and The Rosie Hospital — and a portfolio of digital, research and training products and services. Its core clinical service portfolio is delivered through these hospitals and is supported by digital products such as the MyChart patient portal and the CUH Directions mobile app (both integrating with the underlying Epic electronic health record), data and research platforms including the East of England Secure Data Environment and the Strategic Research Agreement with Arcturis (formerly Sensyne Health), and emerging capital projects such as the CAR-T cell manufacturing laboratory and the planned Cambridge Cancer Research Hospital (target 2029). The Trust also operates the Cambridge Digital Health and Surgical Training Centre, which hosts the START robotic-surgery training programme with the Shelford Group and Newcastle Surgical Training Centre, and uses the NHS Federated Data Platform (via the OPTICA product) for real-time patient discharge tracking and flow optimisation.

Product and service8 records
1Addenbrooke's Hospital
CategoryAcute Hospital
Description

Main acute hospital of Cambridge University Hospitals NHS Foundation Trust, providing emergency, surgical, and medical care to NHS patients across Cambridgeshire, Peterborough, and the East of England region.

2The Rosie Hospital
CategoryMaternity Hospital
Description

CUH's dedicated women's and maternity hospital, co-located with Addenbrooke's, providing maternity services, the Rosie birth centre, neonatal care, and women's health research.

3MyChart Patient Portal
CategoryDigital Health Application
Description

Patient-facing mobile app providing secure online access to hospital information including visits, medications, messages, test results, and appointment management. Integrates with the underlying Epic electronic health record.

4CUH Directions Mobile App
CategoryWayfinding Mobile App
Description

Mobile wayfinding application that helps patients and visitors navigate around the Addenbrooke's and Rosie hospital sites.

5East of England Secure Data Environment (EoE SDE)
CategoryResearch Data Platform
Description

Nationally funded programme hosted by CUH that supports secure access to anonymised data for approved research projects and public interest initiatives, underpinned by a research database with existing CAG and NHS Research Ethics Committee approval.

6Cambridge Digital Health and Surgical Training Centre
CategorySurgical Training Facility
Description

12,000 square foot training facility providing hands-on training on Intuitive da Vinci, CMR Surgical Versius, and Medtronic Hugo RAS robotic surgery systems through the START programme, with a Digital Health Training Centre offering extended reality and AI-based immersive training.

7CAR-T Cell Manufacturing Laboratory
CategoryCell Therapy Manufacturing
Description

State-of-the-art laboratory at Addenbrooke's Hospital, built by the University of Cambridge and operated by CUH, to manufacture CAR-T cells for clinical trials and personalised immunotherapy treatments for cancers and autoimmune diseases.

8CUH Clinical Services A-Z
CategoryClinical Service Portfolio
Description

Full portfolio of clinical services including Emergency Department, Cancer Services, Cardiology, Children's Services, Ear Nose and Throat, Endoscopy, Imaging, Community Diagnostic Centres and Outpatients.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-05-19
Description

NHS Foundation Trust partner hosting the PEMP 500-patient clinical observational study in endometriosis at the Rosie Hospital in Cambridge (with Peterborough City Hospital as the lead site), funded by Cyclana Bio's £5M pre-seed funding round.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-10
Description

Co-delivers the Shelford Surgical Training in Advanced Robotic Technology (START) programme in partnership with the Newcastle Surgical Training Centre from the Cambridge Digital Health and Surgical Training Centre. Provides hands-on training on Intuitive da Vinci, CMR Surgical Versius, and Medtronic Hugo RAS robotic surgery systems.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-10
Description

Co-delivers the Shelford Surgical Training in Advanced Robotic Technology (START) programme alongside the Shelford Group from CUH's 12,000 square foot Cambridge Digital Health and Surgical Training Centre.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-10
Description

Provides support to the Cambridge Digital Health and Surgical Training Centre and the START programme to advance robot-assisted surgery training across the UK.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-12-10
Description

Provider of the da Vinci robotic surgery platform used in hands-on training at the Cambridge Digital Health and Surgical Training Centre's START programme.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-12-10
Description

Provider of the Versius robotic surgery platform used in hands-on training at the Cambridge Digital Health and Surgical Training Centre's START programme.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-12-10
Description

Provider of the Hugo RAS robotic surgery platform used in hands-on training at the Cambridge Digital Health and Surgical Training Centre's START programme.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-10-16
Description

Built the new state-of-the-art CAR-T cell manufacturing laboratory at Addenbrooke's Hospital, with the laboratory operated by Cambridge University Hospitals NHS Foundation Trust. The facility is supported by a £1.4 million grant from the NIHR and aims to manufacture CAR-T cells for clinical trials and personalised immunotherapy treatment for cancers and autoimmune diseases.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2023-11-01
Description

Required by the NHS England Medium Term Planning Framework (Delivering Change Together 2026/27 to 2028/29), CUH uses an instance of the NHS Federated Data Platform including OPTICA, an NECS-built cloud application for tracking admitted patients and discharge tasks. Contract for the FDP supplier was awarded by NHS England in November 2023.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2023-11-01
Description

Builder of OPTICA (Optimised Patient Tracking & Intelligent Choices Application) in collaboration with NHS trusts and local authorities, providing real-time tracking of admitted patients and discharge tasks within the NHS Federated Data Platform.

Strategic tierFlagshipTypeTechnology or IntegrationAnnounced on2021-12-03
Description

Underpins the CUH Digital Research Environment, supporting safe, efficient data processing and rapid transfer of de-identified data for the Sensyne/Arcturis SRA. The Epic EHR also stores patient records, which are subject to long-term retention under the Trust's records management policy.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2021-12-01
Description

Five-year Strategic Research Agreement (SRA) signed in December 2021 granting non-exclusive access to three million longitudinal de-identified patient records for clinical AI research. CUH received 4,285,714 ordinary shares (2.6% of Sensyne) and an investment of up to £350,000 per year over the five-year term, plus royalties on Sensyne's revenues from research under the SRA. Research focus areas include cancer, cardiovascular disease, and rare diseases, including clinical decision tools, AI for retrospective clinical data analysis, and drug discovery.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight8 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

University teaching hospital trust co-located with a world-leading research university; runs a similar mix of acute, specialist, and research services, comparable to CUH in scale, digital maturity, and academic-commercial partnerships.

TypeDirect peer
Description

Large London university teaching trust with a comparable portfolio of acute and specialist services, biomedical campus co-location, and translational research capability directly comparable to CUH's Addenbrooke's-led model.

TypeDirect peer
Description

Major central-London teaching trust combining acute, specialist, and biomedical research on a single campus; operates similar Epic-based digital infrastructure and runs a research/data partnership model analogous to CUH.

TypeDirect peer
Description

Large multi-site teaching trust with extensive research and commercial partnership activity (incl. King's Health Partners); comparable to CUH in research intensity, digital strategy, and teaching hospital remit.

5The Newcastle upon Tyne Hospitals NHS Foundation Trust
TypeDirect peer
Description

Northern England teaching trust and named co-delivery partner with CUH in the Shelford START robotic-surgery training programme; directly comparable in scale, research activity, and surgical training capability.

TypeDirect peer
Description

Major London teaching trust providing tertiary and specialist services (including a large liver/haematology/oncology portfolio); overlaps with CUH in specialist caseload mix and academic-clinical partnership model.

TypeDirect peer
Description

One of the largest UK acute/teaching trusts formed by merger; comparable to CUH in scale, multi-site operating model, and translational research activity.

TypeDirect peer
Description

Large London teaching trust running multiple acute hospitals with significant research output; comparable to CUH in size, digital ambition, and complex public-sector operating environment.

TypeRegional player
Description

Specialist cardiothoracic trust also located on the Cambridge Biomedical Campus, providing tertiary services to the East of England; comparable as a co-located specialist partner rather than a direct acute competitor.

TypeRegional player
Description

UK specialist children's hospital trust with very high research intensity and commercial trial activity; comparable to CUH in translational research model but with a narrower, paediatric specialist scope.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration8 records

Each record includes

Title, Type, Description, Source

AI capability10 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cambridge University Hospitals NHS Foundation Trust

Acute Hospital Servicescuh.nhs.uk

Cambridge University Hospitals NHS Foundation Trust operates Addenbrooke's Hospital and The Rosie Hospital in Cambridge, delivering acute, specialist, maternity and tertiary NHS services to approximately 5 million people across the East of England while serving as a major translational clinical research and AI-data hub.

What Cambridge University Hospitals NHS Foundation Trust does

Cambridge University Hospitals NHS Foundation Trust (CUH) is a UK NHS Foundation Trust — a public benefit corporation — that operates Addenbrooke's Hospital and The Rosie Hospital from a single site on Hills Road, Cambridge, as the regional specialist centre for the East of England. It delivers acute, specialist and tertiary services — emergency care, cancer, cardiology, children's services, maternity, robotic surgery and clinical research — to a population of approximately 5 million, with around 1 million patient contacts per year and 10,000+ employees.

Its technology stack is anchored by an Epic electronic health record that powers the MyChart patient portal and underpins an Epic-based Digital Research Environment used for AI/ML research on de-identified data. The Trust additionally hosts the East of England Secure Data Environment (EoE SDE), runs the OPTICA patient-flow application on the NHS Federated Data Platform, operates a CAR-T cell manufacturing laboratory built with the University of Cambridge, and runs the Cambridge Digital Health and Surgical Training Centre with hands-on training on da Vinci, Versius and Hugo RAS robotic surgery systems plus extended reality and AI-based immersive training.

CUH's revenue model is dominated by statutory NHS funding for public healthcare delivery, supplemented by competitive research grants (e.g., a £1.4m NIHR grant for the CAR-T lab), a five-year Strategic Research Agreement with Arcturis (formerly Sensyne Health) licensing access to 3 million de-identified patient records in exchange for a 2.6% equity stake, up to £350,000/year IT investment and royalties, philanthropic donations via Addenbrooke's Charitable Trust (including a £10m gift), and income from private and overseas patients through the Paying Patients Office. Services are free at the point of use for NHS patients; pricing for non-NHS patients is not publicly listed.

Cambridge University Hospitals NHS Foundation Trust firmographics

Firmographics
Name
Cambridge University Hospitals NHS Foundation Trust
Legal name
Cambridge University Hospitals NHS Foundation Trust
Website
https://cuh.nhs.uk
Company type
Private
Founded year
1992
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Cambridge University Hospitals NHS Foundation Trust operates Addenbrooke's Hospital and The Rosie Hospital in Cambridge, delivering acute, specialist, maternity and tertiary NHS services to approximately 5 million people across the East of England while serving as a major translational clinical research and AI-data hub.
Ownership category
akta.pro rank

Where Cambridge University Hospitals NHS Foundation Trust is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United Kingdom
HQ region
Europe

Offices5 records

Markets served

Cambridge University Hospitals NHS Foundation Trust business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Others

Revenue model

  1. Statutory NHS funding: Primary funding as an NHS Foundation Trust delivering public healthcare services free at the point of use across Cambridgeshire, Peterborough, and the East of England region.
  2. Strategic Research Agreement with Arcturis (formerly Sensyne Health): Five-year SRA signed December 2021 providing non-exclusive access to three million longitudinal de-identified patient records. CUH received 4,285,714 ordinary shares (2.6% of Sensyne) and an investment of up to £350,000 per year, plus royalties on revenues generated by Sensyne from research under the SRA.
  3. Charitable donations via Addenbrooke's Charitable Trust (ACT): Donations and philanthropy supporting the Trust's work, including a £10m donation from a New Zealand businessman to establish the Charlotte Lockhart Precision Breast Cancer Institute.
  4. Research grants (NIHR): Competitive grant funding such as the £1.4 million grant from the NIHR supporting the new CAR-T cell manufacturing laboratory at Addenbrooke's Hospital.
  5. Paying Patients Office (private/overseas patient income): Income from overseas patients and private/overseas patient services managed through the Paying Patients Office.

Go-to-market motion3 records

Distribution channels6 records

Marketing channels7 records

Cambridge University Hospitals NHS Foundation Trust product offering

Product offering

Core offering

Cambridge University Hospitals NHS Foundation Trust operates Addenbrooke's Hospital and The Rosie Hospital in Cambridge, delivering acute, specialist, and tertiary healthcare services to a population of approximately five million across the East of England. The Trust provides a full clinical service portfolio including emergency, cancer, cardiology, children's, maternity, imaging, and outpatient services, supported by digital tools (MyChart, CUH Directions), research platforms (East of England Secure Data Environment), a CAR-T cell manufacturing laboratory, and the Cambridge Digital Health and Surgical Training Centre.

Product overview

Cambridge University Hospitals NHS Foundation Trust (CUH) is a UK NHS acute hospital trust operating two core hospital sites — Addenbrooke's Hospital and The Rosie Hospital — and a portfolio of digital, research and training products and services. Its core clinical service portfolio is delivered through these hospitals and is supported by digital products such as the MyChart patient portal and the CUH Directions mobile app (both integrating with the underlying Epic electronic health record), data and research platforms including the East of England Secure Data Environment and the Strategic Research Agreement with Arcturis (formerly Sensyne Health), and emerging capital projects such as the CAR-T cell manufacturing laboratory and the planned Cambridge Cancer Research Hospital (target 2029). The Trust also operates the Cambridge Digital Health and Surgical Training Centre, which hosts the START robotic-surgery training programme with the Shelford Group and Newcastle Surgical Training Centre, and uses the NHS Federated Data Platform (via the OPTICA product) for real-time patient discharge tracking and flow optimisation.

Differentiator

Problem solved

Functional benefit

Brands

  • MyChart: Patient portal app launched by CUH providing secure online access to health records, appointments, medication, messages and test results.
  • CUH Directions
  • Cambridge Digital Health and Surgical Training Centre
  • Addenbrooke's Charitable Trust (ACT)
  • East of England Secure Data Environment (EoE SDE)

Products and services

  • Addenbrooke's Hospital Main acute hospital of Cambridge University Hospitals NHS Foundation Trust, providing emergency, surgical, and medical care to NHS patients across Cambridgeshire, Peterborough, and the East of England region.
  • The Rosie Hospital CUH's dedicated women's and maternity hospital, co-located with Addenbrooke's, providing maternity services, the Rosie birth centre, neonatal care, and women's health research.
  • MyChart Patient Portal Patient-facing mobile app providing secure online access to hospital information including visits, medications, messages, test results, and appointment management. Integrates with the underlying Epic electronic health record.
  • CUH Directions Mobile App Mobile wayfinding application that helps patients and visitors navigate around the Addenbrooke's and Rosie hospital sites.
  • East of England Secure Data Environment (EoE SDE) Nationally funded programme hosted by CUH that supports secure access to anonymised data for approved research projects and public interest initiatives, underpinned by a research database with existing CAG and NHS Research Ethics Committee approval.
  • Cambridge Digital Health and Surgical Training Centre 12,000 square foot training facility providing hands-on training on Intuitive da Vinci, CMR Surgical Versius, and Medtronic Hugo RAS robotic surgery systems through the START programme, with a Digital Health Training Centre offering extended reality and AI-based immersive training.
  • CAR-T Cell Manufacturing Laboratory State-of-the-art laboratory at Addenbrooke's Hospital, built by the University of Cambridge and operated by CUH, to manufacture CAR-T cells for clinical trials and personalised immunotherapy treatments for cancers and autoimmune diseases.
  • CUH Clinical Services A-Z Full portfolio of clinical services including Emergency Department, Cancer Services, Cardiology, Children's Services, Ear Nose and Throat, Endoscopy, Imaging, Community Diagnostic Centres and Outpatients.

Quantifiable outcome

  • Robot-assisted Whipple's procedures (East of England first) - patients reported minimal pain and speedy recovery compared to traditional surgery which typically requires several months of recovery
  • +3 more outcomes

Companies that use Cambridge University Hospitals NHS Foundation Trust

Customer profile

Segments5 records

Ideal customer profiles5 records

Cambridge University Hospitals NHS Foundation Trust technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration8 records

AI capability10 records

Feature9 records

Cambridge University Hospitals NHS Foundation Trust partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered minor, core and flagship.

  • Cyclana BiominorStrategic or Co-development Partner · 19 May 2026NHS Foundation Trust partner hosting the PEMP 500-patient clinical observational study in endometriosis at the Rosie Hospital in Cambridge (with Peterborough City Hospital as the lead site), funded by Cyclana Bio's £5M pre-seed funding round.
  • Shelford GroupcoreStrategic or Co-development Partner · 10 December 2025Co-delivers the Shelford Surgical Training in Advanced Robotic Technology (START) programme in partnership with the Newcastle Surgical Training Centre from the Cambridge Digital Health and Surgical Training Centre. Provides hands-on training on Intuitive da Vinci, CMR Surgical Versius, and Medtronic Hugo RAS robotic surgery systems.
  • Newcastle Surgical Training CentrecoreStrategic or Co-development Partner · 10 December 2025Co-delivers the Shelford Surgical Training in Advanced Robotic Technology (START) programme alongside the Shelford Group from CUH's 12,000 square foot Cambridge Digital Health and Surgical Training Centre.
  • Royal College of Surgeons of EnglandcoreStrategic or Co-development Partner · 10 December 2025Provides support to the Cambridge Digital Health and Surgical Training Centre and the START programme to advance robot-assisted surgery training across the UK.
  • Intuitive Surgical (da Vinci)coreTechnology or Integration · 10 December 2025Provider of the da Vinci robotic surgery platform used in hands-on training at the Cambridge Digital Health and Surgical Training Centre's START programme.
  • CMR Surgical (Versius)coreTechnology or Integration · 10 December 2025Provider of the Versius robotic surgery platform used in hands-on training at the Cambridge Digital Health and Surgical Training Centre's START programme.
  • Medtronic (Hugo RAS)coreTechnology or Integration · 10 December 2025Provider of the Hugo RAS robotic surgery platform used in hands-on training at the Cambridge Digital Health and Surgical Training Centre's START programme.
  • University of CambridgeflagshipStrategic or Co-development Partner · 16 October 2024Built the new state-of-the-art CAR-T cell manufacturing laboratory at Addenbrooke's Hospital, with the laboratory operated by Cambridge University Hospitals NHS Foundation Trust. The facility is supported by a £1.4 million grant from the NIHR and aims to manufacture CAR-T cells for clinical trials and personalised immunotherapy treatment for cancers and autoimmune diseases.
  • NHS England (NHS Federated Data Platform)coreTechnology or Integration · 1 November 2023Required by the NHS England Medium Term Planning Framework (Delivering Change Together 2026/27 to 2028/29), CUH uses an instance of the NHS Federated Data Platform including OPTICA, an NECS-built cloud application for tracking admitted patients and discharge tasks. Contract for the FDP supplier was awarded by NHS England in November 2023.
  • NECS (North of England Commissioning Support)coreTechnology or Integration · 1 November 2023Builder of OPTICA (Optimised Patient Tracking & Intelligent Choices Application) in collaboration with NHS trusts and local authorities, providing real-time tracking of admitted patients and discharge tasks within the NHS Federated Data Platform.
  • Epic (Electronic Health Record)flagshipTechnology or Integration · 3 December 2021Underpins the CUH Digital Research Environment, supporting safe, efficient data processing and rapid transfer of de-identified data for the Sensyne/Arcturis SRA. The Epic EHR also stores patient records, which are subject to long-term retention under the Trust's records management policy.
  • Arcturis (formerly Sensyne Health)flagshipStrategic or Co-development Partner · 1 December 2021Five-year Strategic Research Agreement (SRA) signed in December 2021 granting non-exclusive access to three million longitudinal de-identified patient records for clinical AI research. CUH received 4,285,714 ordinary shares (2.6% of Sensyne) and an investment of up to £350,000 per year over the five-year term, plus royalties on Sensyne's revenues from research under the SRA. Research focus areas include cancer, cardiovascular disease, and rare diseases, including clinical decision tools, AI for retrospective clinical data analysis, and drug discovery.

Scale indicators11 records

Recent moves8 records

Expansion highlights8 records

Cambridge University Hospitals NHS Foundation Trust competitors and assessment

Company assessment

Direct peers

  • Oxford University Hospitals NHS Foundation Trust: University teaching hospital trust co-located with a world-leading research university; runs a similar mix of acute, specialist, and research services, comparable to CUH in scale, digital maturity, and academic-commercial partnerships.
  • Imperial College Healthcare NHS Trust: Large London university teaching trust with a comparable portfolio of acute and specialist services, biomedical campus co-location, and translational research capability directly comparable to CUH's Addenbrooke's-led model.
  • University College London Hospitals NHS Foundation Trust (UCLH): Major central-London teaching trust combining acute, specialist, and biomedical research on a single campus; operates similar Epic-based digital infrastructure and runs a research/data partnership model analogous to CUH.
  • Guy's and St Thomas' NHS Foundation Trust: Large multi-site teaching trust with extensive research and commercial partnership activity (incl. King's Health Partners); comparable to CUH in research intensity, digital strategy, and teaching hospital remit.
  • The Newcastle upon Tyne Hospitals NHS Foundation Trust: Northern England teaching trust and named co-delivery partner with CUH in the Shelford START robotic-surgery training programme; directly comparable in scale, research activity, and surgical training capability.
  • King's College Hospital NHS Foundation Trust: Major London teaching trust providing tertiary and specialist services (including a large liver/haematology/oncology portfolio); overlaps with CUH in specialist caseload mix and academic-clinical partnership model.
  • Manchester University NHS Foundation Trust: One of the largest UK acute/teaching trusts formed by merger; comparable to CUH in scale, multi-site operating model, and translational research activity.
  • Barts Health NHS Trust: Large London teaching trust running multiple acute hospitals with significant research output; comparable to CUH in size, digital ambition, and complex public-sector operating environment.

Regional players

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Cambridge University Hospitals NHS Foundation Trust social profiles

Digital presence

Cambridge University Hospitals NHS Foundation Trust compliance and trust

Trust signal

Compliance7 records

Cambridge University Hospitals NHS Foundation Trust financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cambridge University Hospitals NHS Foundation Trust leadership team

Management profile

Number of profiles

Profiles2 records

Cambridge University Hospitals NHS Foundation Trust subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Cambridge University Hospitals NHS Foundation Trust funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cambridge University Hospitals NHS Foundation Trust M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cambridge University Hospitals NHS Foundation Trust

What does Cambridge University Hospitals NHS Foundation Trust do?

Cambridge University Hospitals NHS Foundation Trust operates Addenbrooke's Hospital and The Rosie Hospital in Cambridge, delivering acute, specialist, and tertiary healthcare services to a population of approximately five million across the East of England. The Trust provides a full clinical service portfolio including emergency, cancer, cardiology, children's, maternity, imaging, and outpatient services, supported by digital tools (MyChart, CUH Directions), research platforms (East of England Secure Data Environment), a CAR-T cell manufacturing laboratory, and the Cambridge Digital Health and Surgical Training Centre.

Is Cambridge University Hospitals NHS Foundation Trust a public or private company?

Cambridge University Hospitals NHS Foundation Trust is a private company. It is classified as state government owned and is currently operating.

When was Cambridge University Hospitals NHS Foundation Trust founded?

Cambridge University Hospitals NHS Foundation Trust was founded in 1992. It employs 5,001 to 10,000 people.

Where is Cambridge University Hospitals NHS Foundation Trust based?

Cambridge University Hospitals NHS Foundation Trust is headquartered in Cambridge, United Kingdom, in the Europe region.

How does Cambridge University Hospitals NHS Foundation Trust make money?

Five revenue lines are on record. Statutory NHS funding is the primary driver. The others are strategic Research Agreement with Arcturis (formerly Sensyne Health), charitable donations via Addenbrooke's Charitable Trust (ACT), research grants (NIHR) and paying Patients Office (private/overseas patient income).

Who are Cambridge University Hospitals NHS Foundation Trust's main competitors?

Direct peers on record are Oxford University Hospitals NHS Foundation Trust, Imperial College Healthcare NHS Trust, University College London Hospitals NHS Foundation Trust (UCLH), Guy's and St Thomas' NHS Foundation Trust, The Newcastle upon Tyne Hospitals NHS Foundation Trust, King's College Hospital NHS Foundation Trust, Manchester University NHS Foundation Trust and Barts Health NHS Trust. Regional players are Royal Papworth Hospital NHS Foundation Trust and Great Ormond Street Hospital for Children NHS Foundation Trust.

Does Cambridge University Hospitals NHS Foundation Trust have an API?

No public API is recorded for Cambridge University Hospitals NHS Foundation Trust.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Naver케임브리지대 최연소 흑인 교수, 표절 논란 속 숨진 채 발견Jason Adey, a former sociology professor at Cambridge University, was found dead at his home on the 14th, following various allegations regarding his academic achievements and personal history. Adey, who became the youngest Black professor at the university at the age of 37, resigned shortly after the institution announced an investigation into allegations of plagiarism related to his work. His death has prompted discussions about the racial and diversity issues in the UK academia, and the impacts of public scrutiny on individuals within these contexts.Jamaica ObserverUK PM urges ‘reflection’ after Cambridge professor’s deathUK Prime Minister Andy Burnham called for reflection following the death of Jason Arday, a Cambridge University professor who resigned last week amid plagiarism allegations and claims of harassment. His family stated that Arday, who was diagnosed with autism, had been subjected to sustained abuse and misinformation before being found dead in south London. Police are treating the death as unexpected but not suspicious while an investigation into the circumstances continues.SubstackJason Arday's Death and the Age of Digital Racial TerrorThe article reports on the death of sociologist Jason Arday following a sustained campaign of media criticism and allegations regarding his academic work, which led to his resignation from Cambridge University. The author argues that this event exemplifies a broader pattern of digital racial terror orchestrated by British and American media outlets, such as The Telegraph, against Black intellectuals. The piece contextualizes these modern online attacks within historical precedents of white media inciting violence against Black people in both the US and British colonial contexts.HindustantimesJason Arday plagiarism row: What was the Cambridge professor accused of before his sudden death?Jason Arday, Cambridge University's youngest Black professor, passed away at age 41 following a plagiarism controversy that led him to resign just a week prior. Accusations included over 100 plagiarized passages in his dissertation and exaggerated claims about his charity work. His family stated he faced a sustained campaign of abuse, which they believe contributed to his death, described by the police as unexpected but not suspicious.New York PostJason Arday, ex-Cambridge professor accused of plagiarism, found dead in UK week after investigation launchedJason Arday, a former professor at Cambridge University, was found dead in south London shortly after resigning amid an investigation into allegations of plagiarism and resume fraud. The Metropolitan Police confirmed the death is being treated as unexpected but not suspicious, with a file prepared for the coroner. Arday had cited unrelenting public scrutiny as his reason for leaving the university.News-MedicalStudy identifies an important driver of inflammatory bowel diseaseResearchers identified anti-IL-10 autoantibodies in about 3.5% of inflammatory bowel disease patients, a subset linked to a known genetic variant. The findings suggest IBD comprises biologically distinct diseases and could enable targeted blood tests and treatments.Longevity.TechnologyCyclana Bio gains UK approval for study to identify novel targets for endometriosisCyclana Bio received UK approval to launch PEMP, a 500-patient observational study on endometriosis, with recruitment starting at Peterborough and Cambridge hospitals. The study collects biopsies and menstrual fluid to build 3D models and identify novel targets, funded by a £5M pre-seed round. The company plans to expand sites and apply its methodology to other chronic inflammatory conditions.Med-Tech InsightsCyclana Bio granted Health Research Authority approvalCyclana Bio received Health Research Authority and Research Ethics Committee approval for its 500-patient PEMP study on endometriosis. Recruitment began at Peterborough City Hospital and Rosie Hospital, Cambridge, using biopsy and menstrual fluid data to build 3D disease models. The study aims to identify novel therapeutic targets and is funded by a £5M pre-seed round.BBCFirst Addenbrooke's robot abdomen surgery 'milestone' says trustCambridge University Hospitals NHS Trust successfully performed the first robot-assisted Whipple's procedures in the East of England at Addenbrooke's Hospital in Cambridge, marking what the trust called 'a milestone' for the region. Two cancer patients underwent the complex pancreaticoduodenectomy surgery in January, with each operation taking approximately eight hours and requiring two consultant surgeons jointly operating the robotic consoles. Both patients reported minimal pain and speedy recovery compared to traditional surgery, which typically requires several months of recovery.BBCBrain cooling collar trial for Addenbrooke's head injury patientsCambridge University Hospitals NHS Foundation Trust is launching the SELETHERM 2 trial, the world's first in-human study to assess a targeted brain cooling collar developed by Neuron Guard for traumatic brain injury patients. The study will enroll 20 patients over 12 months to compare the selective cooling device against standard therapies, aiming to reduce systemic side effects associated with whole-body cooling.